| 3.14 -0.02 (-0.63%) | 09-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.93  |
1-year : | 4.21 |
| Resists | First : | 3.37 |
Second : | 3.6 |
| Pivot price | 3.31 |
|||
| Supports | First : | 2.99 |
Second : | 2.48 |
| MAs | MA(5) : | 3.18 |
MA(20) : | 3.28 |
| MA(100) : | 2.86 |
MA(250) : | 2.7 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 5.1 |
D(3) : | 8.9 |
| RSI | RSI(14): 46.3 |
|||
| 52-week | High : | 3.6 | Low : | 2.27 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CRON ] has closed above bottom band by 14.9%. Bollinger Bands are 52.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.19 - 3.21 | 3.21 - 3.22 |
| Low: | 3.06 - 3.08 | 3.08 - 3.1 |
| Close: | 3.1 - 3.14 | 3.14 - 3.17 |
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
Sat, 12 Sep 2026
Cronos Group Inc. (NASDAQ:CRON) Given Average Rating of "Hold" by Brokerages - MarketBeat
Fri, 11 Sep 2026
Cronos Extends Long Stop Date for CanAdelaar Acquisition to Oct. 15, 2026 - TradingView
Fri, 11 Sep 2026
Cronos Group Inc. (TSX:CRON) Advances as Cannabis Brand Growth and International Expansion Strengthen Investor Outlook - kalkine.ca
Fri, 11 Sep 2026
Why is Cronos Group (NASDAQ:CRON) stock in focus today? - Kalkine Media
Thu, 10 Sep 2026
Cronos Group (NASDAQ:CRON): What's Moving During A Choppy Session? - Kalkine Media
Wed, 02 Sep 2026
Are Medical Stocks Lagging Cronos Group (CRON) This Year? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 368 (M) |
| Shares Float | 187 (M) |
| Held by Insiders | 49.1 (%) |
| Held by Institutions | 15.5 (%) |
| Shares Short | 3,380 (K) |
| Shares Short P.Month | 3,500 (K) |
| EPS | 0.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.88 |
| Profit Margin | 39 % |
| Operating Margin | 15.4 % |
| Return on Assets (ttm) | -0.2 % |
| Return on Equity (ttm) | 7 % |
| Qtrly Rev. Growth | 58.4 % |
| Gross Profit (p.s.) | 0.2 |
| Sales Per Share | 0.48 |
| EBITDA (p.s.) | 0.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 60 (M) |
| Levered Free Cash Flow | 6 (M) |
| PE Ratio | 16.52 |
| PEG Ratio | 0 |
| Price to Book value | 1.09 |
| Price to Sales | 6.45 |
| Price to Cash Flow | 19.26 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|